Understanding Embryonic Stem Cell Research There are approximately 6,000 posterior diseases that scientists are unfamiliar with how they form or develop in certain people. These diseases affect millions of people around the world. There may be a possible cure for some if not all forms of diseases, even unheard of ones. This is possible due to researchers and scientists understanding the genesis of how the body is formed. Starting from an organ and proceeding backwards, discovering which cells contribute to producing a specific organ. From research, all organs in the body come from a source known as stem cells. Scientists have managed to obtain stem cells and produce new organs. This is all well and good, because diseases of any kind could be cured, but the question is between murder and life. No one on earth, ethically or morally, has the right to take a life, to care for another suffering one for the rest of his life. Who discovered stem cells? Stem cells were discovered by a Russian-American doctor, biologist and scientist better known as Alexander A. Maximow, born on January 22, 1874 in Russia. From 1896 to 1902 Maximow published articles relating to what interested him most, namely histological studies. After a while, Maximow began to develop an interest in blood cells and how they work. “Maximow was the first to demonstrate that all blood cells develop from a common precursor cell, better known as the unitary theory of hematopoiesis.” “The modern idea of ​​the origin and differentiation of blood cells is based mainly on the unitary theory of hematopoiesis.” He proposed the existence of hematopoietic stem cells and described how his unitary theory of hematopoiesis is intertwined with each other. Maximow was the first to… middle of paper… ionic stem cells. “Treatments have been used successfully for many years to treat leukemia and bone- and blood-related cancers through bone marrow transplants.” “Pluripotent stem cells are somatic cells that have been genetically reprogrammed into an embryonic stem cell-like state by being forced to express genes important for maintaining the distinctive properties of embryonic stem cells.” “Although more research is needed, pluripotent stem cells are useful tools for drug development and disease modeling, and scientists hope to use them in transplant medicine. Furthermore, tissues derived from iPSCs will be an almost identical match to the cell donor and will therefore likely avoid rejection by the immune system. By studying iPSCs and other types of pluripotent stem cells, researchers could learn how to reprogram cells to repair damaged tissue in the human body.”